Nov 15, 2023 / 03:15PM GMT
Michael K. Polark - Wolfe Research, LLC - Director & Senior Analyst
I'd like to start these sessions by just giving you the floor kind of state of play, update us on the quarter. I think, John, maybe to give you a specific prompt, you kind of called the current period of transitional time for Tandem. When do we -- when does the transitional period for Tandem end?
Questions and Answers:
John F. Sheridan - Tandem Diabetes Care, Inc. - President, CEO & DirectorStarting right now. I mean I'd say we've had some pressure from the last 18 months. Certainly, we've had some competitive pressures, some economic, hasn't been acting in our favor. I'd say, over the last several quarters this was stabilized. And we're about ready to enter this period of time where we have this wave of innovation that's going to be available for [Tandem].
And I think in my mind, it's the most exciting pipeline of diabetes today. We have 4 products that we're introducing, they are all going to be introduced in the next several weeks [back], I'd say. And the good news is